On October 1, 2016, new codes were implemented in the ICD-10-CM. This was the first update since the original ICD-10-CM version was published in 2015. Among this update is a change to help identify different manifestations for prostate cancer. Show To identify prostate cancer, diagnosis code C61 Malignant neoplasm of prostate was established, as well as “ “use additional code to identify” guidance for hormone sensitivity status and for rising prostate-specific antigen (PSA) following prostate cancer treatment . The ICD-10-CM manual lists the following: C61 Malignant neoplasm of prostate Use additional code to identify Hormone sensitivity status (Z19.1-Z19.2) Rising PSA following treatment for malignant neoplasm of prostate (R97.21) The hormone sensitivity status codes include: Z19.1 Hormone sensitive malignancy status Z19.2 Hormone resistant malignancy status When using diagnosis code C61, you can also add the additional codes for more specific identification. It should not be required to add the codes if they are not relevant. Some clearinghouses are requiring the use of the additional codes before claims are processed but this should not be the case. The AUA has unlimited expert coding advice through the Coding Hotline which is part of the Practice Management Network. For more information on the Coding hotline and other Coding Products please click here. ICD-10 ChapterCodesCode Description2C61Malignant neoplasm of prostate21Z12.5Encounter for screening for malignant neoplasm of prostate21Z80.42Family history of malignant neoplasm of prostate21Z85.46Personal history of malignant neoplasm of prostate"Present On Admission" is defined as present at the time the order for inpatient admission occurs — conditions that develop during an outpatient encounter, including emergency department, observation, or outpatient surgery, are considered POA.
Convert Z80.42 to ICD-9-CM Code History
ICD-10-CM Codes Adjacent To Z80.42 Z79.891 Long term (current) use of opiate analgesic Z79.899 Other long term (current) drug therapy Z80 Family history of primary malignant neoplasm Z80.0 Family history of malignant neoplasm of digestive organs Z80.1 Family history of malignant neoplasm of trachea, bronchus and lung Z80.2 Family history of malignant neoplasm of other respiratory and intrathoracic organs Z80.3 Family history of malignant neoplasm of breast Z80.4 Family history of malignant neoplasm of genital organs Z80.41 Family history of malignant neoplasm of ovary Z80.42 Family history of malignant neoplasm of prostate Z80.43 Family history of malignant neoplasm of testis Z80.49 Family history of malignant neoplasm of other genital organs Z80.5 Family history of malignant neoplasm of urinary tract Z80.51 Family history of malignant neoplasm of kidney Z80.52 Family history of malignant neoplasm of bladder Z80.59 Family history of malignant neoplasm of other urinary tract organ Z80.6 Family history of leukemia Z80.7 Family history of other malignant neoplasms of lymphoid, hematopoietic and related tissues Z80.8 Family history of malignant neoplasm of other organs or systems Z80.9 Family history of malignant neoplasm, unspecified Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes. How do I code history of prostate cancer?Personal history of malignant neoplasm of prostate
Z85. 46 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2023 edition of ICD-10-CM Z85. 46 became effective on October 1, 2022.
Can Z85 3 be used as a primary diagnosis code?Z85. 3 can be billed as a primary diagnosis if that is the reason for the visit, but follow up after completed treatment for cancer should coded as Z08 as the primary diagnosis.
What is the ICDBreast Cancer ICD-10 Code Reference Sheet. What is the ICDICD-10 code C34. 90 for Malignant neoplasm of unspecified part of unspecified bronchus or lung is a medical classification as listed by WHO under the range - Malignant neoplasms .
|